- Conditions
- Head and Neck Neoplasms, Metastatic Salivary Gland Carcinoma, Mouth Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Kaiser Permanente Dublin Dublin, California, United States
- Kaiser Permanente-Fremont Fremont, California, United States
Clinical trial condition
Stage III Major Salivary Gland Cancer AJCC v8
Explore clinical trials studying Stage III Major Salivary Gland Cancer AJCC v8. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Stage III Major Salivary Gland Cancer AJCC v8 trial results
Active, Not Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
NCT04576091
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States